The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field. As the industry endeavours to move gene therapy treatment through the preclinical and clinical pipeline, in context of reducing toxicity and increasing efficacy, attending the 3rd Annual Gene Therapy for Muscular Disorders Summit […]

Welcome to the 11th Alzheimer’s & Parkinson’s Drug Development Summit With a surge in preclinical investment, fresh news of clinical pipeline progressions, and a new era of therapies pending FDA approvals from Biogen, Eisai, and Denali Therapeutics, 2022 has put neurodegenerative drug development back on the map. Building on the field’s momentum, we are delighted to bring back the 11th Alzheimer’s […]

Since Kinase inhibitors have proven to be efficacious and approvable targets, fuelling recent investment into this exciting space as their therapeutic targeting is explored beyond oncology. However, increasing resistance to existing programs and safety bottlenecks threaten further progress. The next wave of kinase targets depends on innovation. Join the 2nd Next Generation Kinase Inhibitors Summit to connect […]

Achieve Therapeutic Localization with Selective, Effective & Validated Delivery to Intracellular Targets Optimize Your Pipeline’s Therapeutic Index with Novel Delivery Systems to Overcome Endosomal Barriers in Target Cells Selective cell entry, biological barriers and complexities in targeting chemistry have long restricted the ability of promising drug candidates to impactfully engage their intracellular sites of action […]

SAE Media Group is proud to present its 4th Annual AI in Drug Discovery Conference, taking place from 13 – 14 March 2023 in London, UK. With the recent pandemic highlighting the need for rapid drug discovery, AI has become an area of increased interest. This is driven by the ability to discover drugs through […]

As the gene therapy field continues to break records, there are still significant challenges to overcome relating to safety, efficacy, and accessibility. The 6th Annual Gene Therapy for Rare Disorders 2023 Summit remains devoted to showcasing the top case studies and strategic learnings from the past year. With an expert speaking faculty devoted to bringing […]

Patient-first. Collaborative. Data and insights driven. Digitally underpinned. These are the qualities of a healthcare system that actively serves its purpose – yet instead, the US is hindered by mounting financial toxicity, unprecedented politicization of science and eroding public trust. To capitalize on three years of extraordinary momentum and lead healthcare’s reform, pharma must embody […]

Dedicated to driving cost-effective, efficacious, safe, durable, scalable, and globally accessible allogeneic, cell-based, and engager therapies, the 8th Innate Killer Summit returns to cement your end-to-end education in innate immune therapeutics. Your industry-defining Innate Killer Summit brings crucial insights for everyone on your team, with 4 content tracks spanning preclinical development, clinical translation, CMC, process development, and clinical scale manufacturing, this is the definitive meeting to […]

The first TCR-based therapy approval in the US and Europe at the start of last year sparked a rush of excitement, investment and collaborations. As further developers move into the clinic and some near commercialization, it’s time for this community to unite to address the critical bottlenecks faced in development, from discovery to approval, to […]

Hijacking E3 Ligases to Mediate Degradation & Modulation of Undrugged Targets As a family of over 600 known proteins, ligases pose immense potential as viable avenues for harnessing previously undrugged targets. Key challenges remain however to rapidly discover and identify novel and underexploited ubiquitin E3s. Furthermore, bottlenecks exist in the development of the established ligases; […]

Turbocharging Your Next Gen LNP End-To-End Development to Deliver Curative Promises to Patients Following exciting industry updates from Verve Therapeutics’ GalNAc-LNP for PCSK9 for HFpEF treatment, to Recode’s 5th element, the 2nd LNP Formulation & Process Development Summit is your must-attend meeting as this nanoparticle continues to dominate the biopharmaceutical industry in 2023. New for […]

The field of FcRn receptor targeting is gaining ground-breaking speed as Argenx, Janssen, UCB and Immunovant compete to tackle myasthenia gravis and biopharma invest in transformative immunological therapy for autoimmune diseases as the next big drug opportunity. The 3rd Fc Receptor Pathway Targeted Therapies Summit will once again feature unmissable conversations to advance targeting FcR […]

mRNA therapeutics have catapulted into the limelight amidst the COVID-19 pandemic with multiple EMA approvals to help combat the virus. Bringing together KOLs sharing case studies with actionable insights, the inaugural mRNA Process Development & Manufacturing Summit Europe has been established as the first forum in Europe to support your in-house process development and manufacturing […]

10th Annual Pre-Filled Syringes East Coast Conference April 24 – 25, 2023 Boston, USA Driving Innovations in Device Design, Connectivity and Sustainability for Advanced Parenteral Combination Product https://www.pfsamericas.com/PJ-Event-listing The 10th annual Pre-Filled Syringes East Coast conference will once again play host to an international audience of drug delivery, medical device and PFS experts to discuss […]

Welcome to the Next Generation Cardiovascular Drug Development Summit Executing Cell & Gene Therapy for Cardiac Regeneration Following technology advancements and the surge of investment in developing the next generation of cardiovascular disease drugs, the opportunity to successfully leverage our knowledge of CRISPR/Cas9, siRNA, autologous iPSC therapy, capsid engineering, and digital medicine to reduce the soaring fatality rate has never been […]

The 5th Annual Cell Engager Summit is back in Boston, MA this year – the only industry-led meeting bringing together 100+ pharma and biotech leaders will assemble for a 3-day agenda including 4 unique pre-conference workshops to delve into the biggest challenges cell engager therapeutics face. Breaking into the solid tumor, preventing CRS and maximizing the quality of insights we gain from […]

With increasing prioritization for neuroscience discovery, huge biopharma is investing in expanding its departments, focusing on glial biology, neuroinflammatory biomarkers, and optimizing various approaches to target the likes of LRKK2, TREM2, and more. Therefore, there is a great amount of novel and promising research to be discussed in 2023. Uniting 100+ neuroinflammation and neuroimmunology experts […]

Uniting the leading minds in gene therapy at the Gene Therapy Durability Summit, join us to: Leverage knowledge from current clinical trials with relevant durability data across a range of indication types using AAV Better understand what can be extrapolated and how to gain confidence in the data collected Build study designs with durability in […]

The 2nd ADC Analytical Development Summit (April 25-27, 2023 | Boston, MA) is the only meeting focused on optimizing the application of analytical technologies for ADC, from drug-linker and drug substance through to drug product to guide regulatory specifications and submissions, to enhance understanding of your drug and to exert control over your process. See […]

6th Annual Pharmaceutical Microbiology USA Conference April 26 – 27, 2023 Boston, MA, USA http://www.pharma-microbiology-usa.com/PharmaJournalistWL Sponsored by: LONZA Chaired by: Donald Singer, USP General Chapter Committee Microbiology Chair, US Pharmacopeia  Contamination Control and Microbial Methods Explored to Assure Product Quality and Prevention Microbiology remains an essential tool in reducing microbial growth in the manufacture of pharmaceuticals, […]

Uniting leading CMC, Regulatory, QC, Analytical and Process Development experts, the 4th Annual Gene Analytical Development Europe Summit is the industry’s definitive and only meeting focused on tackling the greatest analytical development challenges in the context of gene therapy drug development. Hear from the likes of AstraZeneca, MHRA, Gyroscope, REGENXBIO, Biogen, Spark Therapeutics, and more […]

Facilitating key conversations needed to drive forward the development of safe and effective innate stimulating immunotherapies, the 4th STING & TLR Targeting Therapies Summit will take place, for the first time ever in person, in Boston on May 9-11, 2023. View the official program here. Explore innate agonists from discovery to translation with the leaders in the space and […]

The Global High Potency API/HPAPI Market is projected to reach 37 billion USD by 2027, growing at an ever-increasing CAGR of 8.43%. The expanding production of high potency APIs, along with the increase in associated toxicities, are driving requirements for more effective containment solutions and much-needed guidelines to ensure worker safety. Our 2023 conference brings […]

Exploring Injectable Drug Formulations and Device Development Sponsors: Victrex Exhibitors: PHC Group  As Part of Europe’s leading Injectable conference series, the 5th annual Injectable Drug Delivery conference will assess innovations in drug product formulation and biologics, new technologies in device design, along with the latest regulatory considerations for optimal drug delivery. With increasing demand for […]

It’s a painful moment for healthcare. We face rampant burn out, squeezed operating margins, unhappy patients, massive cost pressures and more competition than ever as disruptors continue to flood the market with convenient, accessible care options. It’s high time we collaborate around Digital Health. We must listen, take note and work to implement the changes […]

With 3 days of jam-packed content and 35+ world class speakers pioneering the next wave of ALS therapies, the 2nd ALS Drug Development Summit is biopharma’s can’t-miss meeting for the acceleration of ALS drug development pipelines. Join 100+ of your biopharma peers to uncover cutting-edge ALS biomarkers, including neurofilament light chain, to incorporate into clinical trials, improve in vitro and in vivo ALS […]

With investment into the Treg field at an all time high, excitement is overflowing at the prospect of these remarkable cells being game-changers in the long-term treatment of autoimmunity, inflammation and transplantation. As this enthusiasm coincides with multiple clinical readouts and several more therapies entering the clinic, it remains vital for Treg trailblazers to come together to recognize therapy efficacy, determine […]

The 2nd Cell Therapy Potency Assay will gather 100+ experts working to rationally design better potency assays to smooth the path to regulatory approval and minimize hold times with scientifically rigorous and informative potency measurements. Whether you are submitting your first IND or gearing up towards BLA submission, this critical meeting of minds is your premier opportunity to join the likes […]

Whether it’s in cardiovascular disease, Alzheimer’s or osteoarthritis, therapeutic innovations to target the mechanisms of aging are making significant headway to clinical trials. With increased investments and recognition, along with the escalation of the burden of age-related disease, research and development to meet this unmet medical need has never been more important. The 5th Age-Related Disease Therapeutics Summit is […]

With approvals in siRNA technology, more ASOs hurtling towards human trials in neurology, and exciting headlines in Alzheimer’s and ALS, the draw of CNS targets for oligonucleotides has never been greater. Massive investments and growing pipelines in pharma and biotech alike are working to make these life-changing therapies a reality for previously undruggable targets. Join […]